France's Innopsys Says Array Scanner Sales Rose 25 Percent in '09; Firm Plans US Marketing Effort | GenomeWeb

By Justin Petrone

Innopsys, a French microarray scanner and software maker, this week reported a 25-percent spike in 2009 receipts and a 30-percent increase in first-quarter sales.

The privately held company, based in Carbonne, said it expects total 2010 revenue to increase 30 percent to $2.6 million as it focuses on the US market.

For the 12 months ended Dec. 31, 2009, Innopsys' revenues rose 25 percent to $2 million from $1.6 million in 2008.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.